Sunlink Health Systems Inc (SSY) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket
 


Sunlink Health Systems Inc   (NYSEAMER: SSY)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Sunlink Health Systems Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sunlink Health Systems Inc's ROI in the third quarter of 2025?
Sunlink Health Systems Inc achieved a return on average invested assets (ROI) of 11.72 % in its third quarter of 2025, this is above SSY's average return on investment of 1.36%.
Sunlink Health Systems Inc invested over the 12 months ending in its third quarter of 2025 $15 million

ROI has improved compared to 7.01% in the second quarter of 2025, due to net income growth.

Within the Healthcare sector 83 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 603 to 653.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2025)
III. Quarter
(Dec 31 2024)
II. Quarter
(Sep 30 2024)
I. Quarter
(Jun 30 2024)
IV. Quarter
(Mar 31 2024)
III. Quarter
Y / Y Investment Change TTM 1.34 % -12.58 % -22.05 % -22.79 % -23.77 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 13 14 15 16 12
Return On Investment (TTM) 11.72 % 7.01 % -5.23 % -10.78 % -49.85 %
SSY's Overall Ranking # 653 # 603 # 2726 # 2937 # 0
Seq. Investment Change TTM 3.16 % 1.92 % -1.16 % -2.49 % -11.01 %
Seq. Net Income Change TTM 72.5 % - - - -
Net Income (TTM) in Millions 2 1 -1 -2 -7




Return On Investment SSY's Ranking
Within: No.
Industry # 5
Sector # 84
Overall # 653

Return On Investment Statistics
High Average Low
81.81 %
1.36 %
-77.07 %
(Dec 31 2020)   (Jun 30 2016)







Financial Statements
Sunlink Health Systems Inc's III. Quarter Investments $ 13 Millions SSY's Balance sheet
Sunlink Health Systems Inc's III. Quarter Income $ -1 Millions Quarterly SSY's Income Statement
SSY's Income by Division See SSY's Income by Division


SSY Annual Return On Investment (Jun 30 2024)
2024
(Jun 30 2023)
2023
(Jun 30 2022)
2022
(Jun 30 2021)
2021
(Jun 30 2020)
2020
Total Investments in Millions 16 17 18 20 29
Y / Y Investment Growth -8.29 % -4.97 % -9.84 % -29.68 % -5.86 %
Net Income in Millions -2 -2 -2 7 -1
Y / Y Net Income Growth - - - - -
Annual Return On Investment -9.56 % -10.31 % -10.96 % 33.89 % -3.94 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SSY's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SSY's Competitors
Subscribers only: Roi for Sunlink Health Systems Inc's Suppliers
Subscribers only: Return On Investment for SSY's Customers

Other Ratios
SSY's Roa SSY's Inventory Turnover Ratio SSY's Growth Rates SSY's Dividend Statistics
SSY's Profitability Ratios SSY's Asset Turnover Ratio SSY's Dividend Growth
SSY's Roe SSY's Valuation Ratios SSY's Financial Strength Ratios SSY's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI
Nutriband Inc   30.51 %
Carlisle Companies Incorporated  29.62 %
Catalyst Pharmaceuticals Inc   28.11 %
Nrc Health  26.31 %
Whitehawk Therapeutics Inc   26.03 %
Halozyme Therapeutics Inc   24.84 %
Siga Technologies Inc  24.48 %
Lifevantage Corp  22.87 %
Eli Lilly And Company  22.61 %
Iradimed Corporation  22.50 %
Pro dex Inc   22.32 %
Biomx Inc  21.77 %
Merck and Co Inc   21.45 %
Alkermes Plc   21.09 %
Zoetis Inc   21.02 %
Abbott Laboratories  20.40 %
Resmed Inc   20.20 %
Chemed Corporation  19.89 %
Corcept Therapeutics Inc  19.81 %
Mimedx Group Inc   19.12 %
Third Harmonic Bio Inc   19.10 %
United Therapeutics Corporation  18.78 %
Harmony Biosciences Holdings inc   18.53 %
Agilent Technologies inc   17.97 %
Stoke Therapeutics Inc   17.88 %
Minerva Neurosciences Inc   17.19 %
Electromed Inc   16.34 %
Johnson and Johnson  15.95 %
Dr Reddy s Laboratories Limited  15.80 %
Lantheus Holdings Inc   15.68 %


Date modified: 2026-09-08T15:11:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.